Trial intelligence / Profile preview

Microbiota Changes in Psoriasis Under Systemic Therapy

DRKS00007147Phase 4Completed

Sponsor
Universitätsklinikum Münster
Start
Mar 2015
Modality
Small Molecules, Peptides, Monoclonal Antibodies → Antibody-Based Therapeutics
Countries
1
01

Overview

A Phase 4 trial of adalimumab, ustekinumab, cyclosporine in plaque psoriasis, sponsored by Universitätsklinikum Münster. Started Mar 2015; status: completed.

02

Drugs

adalimumabustekinumabcyclosporine
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on DRKS00007147.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00007147.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call